News
Featured News
Flexibility, creativity, and dedication to make better therapeutics are at the heart of what we do. Read more on recent updates and highlights around our contract drug manufacturing activities.
Agilent Completes Acquisition of BIOVECTRA
September 20, 2024
BIOVECTRA wins BIOTECanada’s Gold Leaf Award for Company of the Year!
CANADIAN BIOTECH INDUSTRY RECOGNIZES TOP PERFORMERS DURING GLOBAL BIOTECH WEEK September 26, 2018 [OTTAWA] – BIOTECanada is pleased to announce the 2018 winners of the […]
BIOVECTRA and TUBE Biopharmaceuticals Sign Exclusive License for Microbial Fermentation Technology to Manufacture Tubulysins
BIOVECTRA and TUBE Biopharmaceuticals Sign Exclusive License for Microbial Fermentation Technology to Manufacture Tubulysins 16/07/18 – CHARLOTTETOWN, Prince Edward Island, Canada – Today, BIOVECTRA Inc., […]
Windsor Expansion Helps BIOVECTRA Meet Global Market Demand
Windsor Expansion Helps BIOVECTRA Meet Global Market Demand Extensive facility renovation, new equipment, assists life sciences firm in creating jobs, growing regional economy April 12, […]
BIOVECTRA and Keryx Biopharmaceuticals Enter Agreement for Ferric Citrate Production Expansion
BioVectra Inc., an innovative global contract development and manufacturing organization (CDMO), today announced a long-term supply agreement with Keryx Biopharmaceuticals, […]
<a class="btn btn-secondary understrap-read-more-link"
BIOVECTRA Inc. Celebrates the Opening of Flagship Warehouse & Process Development Suites as part of Global Biotech Week
BioVectra Inc. is proud to announce the opening of a new flagship warehouse and process development suites in Charlottetown, Prince Edward Island. […]
<a class="btn
BIOVECTRA Inc. to Open New Microbial Fermentation and Complex Chemistry Site in December 2017
$30 million investment increases BioVectra’s total manufacturing capacity by 40% […]
